CODEX’s spatial phenotyping capabilities will contribute to HCA investigators’ ability to build comprehensive tissue maps. MARLBOROUGH, Mass. — March 23,
MINNEAPOLIS and AUSTIN, Texas, March 3, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for
Investment will bring Canada’s first centre of manufacturing excellence of nanomedicine-based RNA vaccines, gene therapies and cell therapies. At project
Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for
PNI will use the investment to advance a cost-effective Made-in-Canada COVID-19 vaccine PNI offers expertise in self-amplifying mRNA vectors, lipid-based